“…At a genetic level, both gain‐ and loss‐of‐function HCN1 variants, as measured in heterologous expression assays, associate with epilepsy (Marini et al, 2018; Nava et al, 2014). Pharmacologically, the broad‐spectrum I h blockers ivabradine, caesium and ZD7288 all have anticonvulsant activity in seizure models (Kitayama et al, 2003; Luszczki, Prystupa, Andres‐Mach, Marzeda, & Florek‐Luszczki, 2013; Matsuda, Saito, Yamamoto, Niitsu, & Kogure, 2008). Together, these data suggest that HCN channels, as a class, are important modulators of neuronal excitability in epilepsy.…”